SaifAnwaruddinMDFACC FSCAI

Adult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Cardiothoracic Imaging

Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Anwaruddin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anwaruddin's full profile

Already have an account?

Office
9200 W Wisconsin Ave
Milwaukee, WI 53226
Phone+1 414-805-6000

Fax+1 414-805-6280

Summary

Board Certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology. Current practice includes the diagnosis and treatment of various types of cardiovascular disease including complex coronary artery disease, peripheral arterial disease, and structural heart/valvular disease, including transcatheter valve therapies.

Education & Training

Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2008 - 2010
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2005 - 2008
Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2005
Massachusetts General HospitalInternship, Internal Medicine, 2002 - 2003
University of Massachusetts Medical SchoolClass of 2002

Certifications & Licensure

MA State Medical License 2004 - 2025
WI State Medical License 2024 - 2025
PA State Medical License 2011 - 2022
OH State Medical License 2005 - 2011
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Member Alpha Omega Alpha, 2002
Fellow (FACC) American College of Cardiology

Clinical Trials

Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study) Start of enrollment: 2008 Jul 01
Completed
Phase 2
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk Start of enrollment: 2011 Mar 01
Completed
Not Applicable
REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm Start of enrollment: 2012 Apr 01
Completed
Not Applicable
Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery Start of enrollment: 2011 Sep 01
Unknown status
Phase 4
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
Active, not recruiting
Not Applicable
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
Terminated
Phase 3
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. Start of enrollment: 2012 Jul 01
Unknown status
Phase 2
Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study Start of enrollment: 2013 Jan 01
Completed
Not Applicable
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure Start of enrollment: 2013 Oct 01
Unknown status
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

34 citations
Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial.
Sony Tuteja, Henry A. Glick, William H. Matthai, Irving Nachamkin, Ashwin S. Nathan
Circulation. Genomic and Precision Medicine. 2020-01-10
343 citations
Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failu...
Emerson C. Perin, James T. Willerson, Carl J. Pepine, Timothy D. Henry, Stephen G. Ellis
JAMA. 2012-04-25
842 citations
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
James L. Januzzi, Carlos A. Camargo, Saif Anwaruddin, Aaron L. Baggish, Annabel A. Chen
The American Journal of Cardiology. 2005-04-15

Journal Articles

Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement with Extremely Large Annuli Using the Edwards SAPIEN 3 Valve
Omar K Khalique, Raj R Makkar, Norihiko Kamioka, Vasilis Babaliaros, Joseph A Kozina, Saif Anwaruddin, Dinesh Jagasia, Howard C Herrmann, Sukhdeep S Basra, Molly A Sze..., JACC: Cardiovascular Imaging

Lectures

United States
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
Right Sided Valve Disease Interventions
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Tricuspid Valve Interventions: Valve in Valve Interventions
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

Systematic Approach Toward Transcatheter Treatment of BAV Disease One Size Does Not Fit AllSeptember 2020
Systematic Approach Toward Transcatheter Treatment of BAV Disease One Size Does Not Fit AllSeptember 2020

Press Mentions

Researchers Examine ‘Concerning’ Out-of-Hospital 30-Day Mortality Rate for TAVR PatientsFebruary 3rd, 2021
Is There a Volume-Outcome Relationship in TAVR?January 28th, 2019
Transcatheter Heart Valve Handbook: A Surgeons' and Interventional Council ReviewDecember 7th, 2018
Join now to see all